Suchergebnisse - "Sáez-Llorens, Xavier"

PubPharm (125)

1

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Global health | 2024

von Tricou, V. | Yu, D. | Reynales, H. | +29

2

Norovirus in children under 2 years of age : an epidemiological study in Panama during the COVID-19 pandemic

enthalten in: Frontiers in pediatrics | 2024

von DeAntonio, R. | Hess-Holtz, M. | Abrego, L. | +6

3

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age : A Phase 1/2 Randomized Trial

enthalten in: The Journal of infectious diseases | 2024

von Sáez-Llorens, X. | Norero, X. | Mussi-Pinhata, M. | +38

4

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age : A phase 2 randomized, double-blind trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von López, P. | López-Medina, E. | Sáez-Llorens, X. | +6

5

Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama

enthalten in: bioRxiv.org | 2023

von Villarreal, A. | Rangel, G. | Zhang, X. | +24

6

Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults : A phase 2 randomized study" [Vaccine: X 11 (2022) 100189

enthalten in: Vaccine: X | 2023

von Sáez-Llorens, X. | Lanata, C. | Aranguren, E. | +20

ErratumFor: Vaccine X. 2022 Aug;11:100189. - PMID 35791320

7

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

enthalten in: The Journal of infectious diseases | 2023

von Díez-Domingo, J. | Sáez-Llorens, X. | Rodriguez-Weber, M. | +22

8

Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

enthalten in: The Lancet. Global health | 2023

von Carbonell-Estrany, X. | Simões, E. | Bont, L. | +79

9

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

enthalten in: The New England journal of medicine | 2023

von Muller, W. | Madhi, S. | Seoane Nuñez, B. | +115

10

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue

enthalten in: The American journal of tropical medicine and hygiene | 2023

von Sáez-Llorens, X. | Biswal, S. | Borja-Tabora, C. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]